Nicotine receptor partial agonists for smoking cessation.

Journal article

BACKGROUND: Nicotine receptor partial agonists may help people to stop smoking by a combination of maintaining moderate levels of dopamine to counteract withdrawal symptoms (acting as an agonist) and reducing smoking satisfaction (acting as an antagonist). OBJECTIVES: The primary objective of this review is to assess the efficacy and tolerability of nicotine receptor partial agonists, including cytisine, dianicline and varenicline for smoking cessation. SEARCH METHODS: We searched the Cochra...

Expand abstract

Authors: Cahill, K; Stead, L; Lancaster, T

• Publication status: Published
• Journal: Cochrane database of systematic reviews
• Volume: 4
• Issue: 4
• Pages: CD006103
• Publication date: 2012-01-01
• DOI: 10.1002/14651858.cd006103.pub6
• EISSN: 1469-493X
• ISSN: 1469-493X
• Language: English
• Keywords: Counseling; Alkaloids; Quinoxalines; Heterocyclic Compounds with 4 or More Rings; Substance Withdrawal Syndrome; Randomized Controlled Trials as Topic; Benzazepines; Quinolizines; Bupropion; Azocines; Smoking Cessation; Smoking; Nicotinic Agonists; Humans; Azepines; Nicotine